★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Gene Editing Skyrockets into November on New CRISPR Breakthroughs New research on CRISPR techniques that could provide treatments and improved diagnostics for several major viruses and other medical conditions…McAlinden Research PartnersNovember 13, 2019
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & Healthcare Gene-Editing Revenues Beat Wall Street Bets While Novel Methods Promise Thousands more CRISPR Treatments New developments in CRISPR gene editing technology have opened the door to potential cures for 89% of known disease-causing genetic…McAlinden Research PartnersOctober 29, 2019
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & Healthcare Opioid Defendants Manage to Delay Trial, but Settlement Plans Slipping Away As the massive 2700-case litigation against major producers and distributors of opioids continues in Ohio, many lawyers and Attorneys General…McAlinden Research PartnersOctober 23, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Digital Therapeutics Bring Additional Disruption to Health Care The prevalence of chronic diseases combined with their sky-high price tags is drawing interest to digital therapeutics (DTx), a new…McAlinden Research PartnersOctober 21, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Landmark Opioid Suit Sets Dangerous Precedent for Big Pharma In two back-to-back blockbuster headlines, Johnson & Johnson was found liable for damages related to the US opioid crisis and…McAlinden Research PartnersAugust 28, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Drugmaker Difficulties Piling Up From Courtrooms, Congress, and China As litigation against some of the world’s foremost drugmakers finally enters the courtroom, some companies have already settled a number…McAlinden Research PartnersJune 25, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare CRISPR Becoming a Mainstay is Great News for Investors, Bad News for Some Healthcare Segments After some major hiccups last year, new breakthroughs suggest CRISPR is becoming a mainstay in healthcare. The technology is now…McAlinden Research PartnersMay 28, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Major Drugmakers Face Declining Sales, New Disruptors, and Democrat-Led Regulations At first glance, first quarter earnings for the pharmaceutical sector appear to be largely positive, with only a few nuggets…McAlinden Research PartnersMay 1, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Obesity’s Tipping Point: More people are Now Obese than Underweight Globally The world is seeing an escalation of obesity due to energy-sparing technology, sugary drinks, packaged or fast food, and the…McAlinden Research PartnersMarch 25, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Big Tech in the Digital Age of Healthcare: App-Based Diagnostics As the supply of doctors is projected to become increasingly insufficient over the next decade and beyond, healthcare providers will…McAlinden Research PartnersMarch 20, 2019